An integrative medicine approach to premenstrual syndrome

Clinical Journal of Women's Health

Volumn 2, Issue 3, 2002, Pages 116-127

  Girman, Andrea ^a   Lee, Roberta ^a   Kligler, Benjamin ^a  

^a Department of Pain Medicine and Palliative Care   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGNOLYT; ANEMONE EXTRACT; ANGELICA SINENSIS EXTRACT; BROMOCRIPTINE; CAFFEINE; CALCIUM CARBONATE; CAULOPHYLLUM EXTRACT; CIMICIFUGA RACEMOSA EXTRACT; CYCLOSPORIN; DIOSCOREA EXTRACT; DIURETIC AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; GINKGO BILOBA EXTRACT; HORMONE; HYPERICIN; HYPERICUM PERFORATUM EXTRACT; KAVA EXTRACT; MAGNESIUM ASPARTATE; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PHOTOSENSITIZING AGENT; PLANT EXTRACT; PRIMROSE OIL; PROTEINASE INHIBITOR; PYRIDOXINE; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG; VIBRIUM EXTRACT; VIBURNUM EXTRACT; VITEX AGNUS CASTUS EXTRACT;

ALTERNATIVE MEDICINE; ANEMONE; ATAXIA; BEHAVIOR THERAPY; BIBLIOGRAPHIC DATABASE; CAULOPHYLLUM; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITIVE THERAPY; DIARRHEA; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG POTENTIATION; EVIDENCE BASED MEDICINE; EXERCISE; FEMALE; GROUP THERAPY; HEARTBURN; HERBAL MEDICINE; HUMAN; HYPERMENORRHEA; LIVER TOXICITY; MANIPULATIVE MEDICINE; MASSAGE; MEDICAL LITERATURE; MEDICINAL PLANT; MEDLINE; NAUSEA; NEUROPATHY; NONHUMAN; NUTRITIONAL SUPPORT; PHOTOTHERAPY; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PSYCHOPHYSIOLOGY; RELAXATION TRAINING; REVIEW; SEIZURE; STOMACH DISEASE; VIBRIUM; VIBURNUM; WEIGHT GAIN; YAM; YOGA;

EID: 0036767764     PISSN: 15270289     EISSN: None     Source Type: Journal    
DOI: 10.1053/cjwh.2002.130402     Document Type: Review

References (102)

1. Reid R: Premenstrual syndrome. N Engl J Med 324:1208-1210, 1991
2. Mortola J: Premenstrual syndrome-pathophysiologic considerations. N Engl J Med 338:356-257, 1998
3. Singh B, Berman B, Simpson R, et al: Incidence of premenstrual syndrome and remedy usage: a national probability sample study. Altern Ther Health Med 4:75-79, 1998
4. Snyderman R, Weil AT: Integrative medicine: bringing medicine back to its roots. Arch Int Med 162:395-397, 2002
5. Bell IR, Caspi O, Schwartz GE, et al: Integrative medicine and systematic outcomes research. Arch Int Med 162:133-140, 2002
6. Chrousos GP, Torpy DJ, Gold PW: Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: Clinical implications. Ann Intern Med 129:229-240, 1998
7. Johnson SR: Premenstrual syndrome therapy. Clin Obstet Gynecol 41:405-421, 1998
8. Wyatt K, Dimmock P, Jones P, et al: Efficacy of progesterone and progestogens in management of premenstrual syndrome: Systematic review. BMJ 323:776-780, 2001
9. Abraham G: Nutritional factors in the etiology of the premenstrual tension syndrome. J Reprod Med 28:446-464, 1983
10. Rossignol AM: Caffeine-containing beverages and premenstrual syndrome in young women. Am J Public Health 75:1335-1337, 1985
11. Rossignol AM, Zhang JY, Chen YZ, et al: Tea and premenstrual syndrome in the People's Republic of China. Am J Public Health 79:67-69, 1989
12. Low Dog T: Integrative treatments for premenstrual syndrome. J Alt Therap Health Healing 7:32-39, 2001
13. Rosentein DL, Elin RJ, Hosseini JM, et al: Magnesium measures across the menstrual cycle in premenstrual syndrome. Biol Psychiatry 35:557-561, 1994
14. Proctor ML, Murphy PA: Herbal dietary therapies for primary and secondary dysmenorrhea (Cochrane Review). The Cochraine Library, Issue 2, 2002. Oxford: Update Software
15. Seifert B, Wagler P, Dartsch S, et al: Magnesium-a new therapautic alternative in primary dysmenorrhea. Zentralblatt fur Gynakologie 111:755-760, 1989
16. Altura BM, Altura BT: New perspectives on the role of magnesium in the pathophysiology of the cardiovascular syatem. II. Experimental aspects. Magnesium 4:245-271, 1985
17. Schindler R, Thoni H, Classen HG: The role of magnesium in the generation and therapy of benign muscle cramps. Combined in-vivo/invitro studies on rat phrenic nerve-diaphragm preparations. Arneimittel-Forschung 48:161-166, 1998
18. Proctor ML, Murphy PA: Herbal dietary therapies for primary and secondary dysmenorrhea (Cochraine Review). The Cochraine Library, Issue 2, 2002. Oxford: Update Software
19. Ebadi M, Govitrapong P: Pyridoxal phosphate and neuro-transmitters in the brain, in Tryiates G (ed): Vit B6: Metabolism and the role in Growth. Westport, CT, Food and Nutrition Press, 1980, p 223
20. Wyatt K, Kimmocks P, Jones PA, et al: Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. BMJ 318:1375-1381, 1999
21. Blue J, Harman J: Mastalgia review: St Marks Breast Center. NZ Med J 111:34-37 1998
22. Cohen M, Bendich A: Safety of pyridoxine - A review of human and animal studies. Toxicol Lett 34:129-139, 1986
23. Krinke G, Nalyor DC, Skorpil V: Pyridoxine megavitaminosis an analysis of the early changes induced with massive dosed of vitamin B6 in rat primary sensory neurons. J Neuropathol Exp Neurol 44:117-129, 1985
24. Schaeppi U, Krinke G: Pyridoxine neuropathy: correlation of functional tests and neuropathology in beagle dogs treated with large doses of vitamin B6. Agents Actions 12:575-582, 1982
25. Thys-Jacobs S: Micronutrients and the premenstrual syndrome: the case for calcium. J Am Coll Nutr 19:220-227, 2000
26. Thys-Jacobs S, Starkey P, Bernstein D, et al: Calcium carbonate and the premenstrual syndrome: Effects on premenstrual and menstual symptoms. Premenstrual Syndrome Study Group. Am J Obstet Gynecol 179:444-452, 1998
27. Thys-Jacobs S, Starkey P, Bernstein D, et al. Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstual symptoms. Premenstrual Syndrome Study Group. Am J Obstet Gynecol 179:444-452, 1998
28. Ross EA, Szabo NJ, Tebbet IR: Lead content of calcium supplements. JAMA 284(11):1425-1429, 2000
29. Ward MW, Holimon TD: Calcium treatment for premenstrual syndrome. Ann Pharmacother 33:1356-1358, 1999
30. Bourgoin BP, Evans DR, Cornett JR, et al: Lead content in 70 brands of dietary calcium supplements. Am J Public Health 83:1155-1160, 1993
31. US Food and Drug Administration: Provisional tolerable exposure levels for lead [Memorandum]. Washington, DC, US Public Health Service, Contaminants Tem HFF-156, November 16, 1990
32. Haney R: Lead in calcium supplements cause for alarm or celebration? JAMA 204:1432-1433, 2000
33. Blumenthal M, Busse WR, Goldberg A, et al: The complete German Commission E monographs: therapeutic guide to herbal medicines. Austin, TX, American Botanical Council, 1998, p 1694
34. Schultz V, Hansel R, Tyler V: Rational Phytotherapy: A Physician's Guide to Herbal Medicine (ed 3). Berlin, Germany, Springer, 1997, p 240
35. Mills S, Bone K: Principles and Practice of Phytotherapy. London, Churchill Livingstone, 2000
36. Chasteberry Monograph. Available at: www. naturaldatabase.com. Accessed June 17, 2002
37. Merz PG, Gorkow C, Schrodter A, et al. The effects of special Agnus castus extract (BP1095E1) on prolactin secretion in healthy male subjects. Exp Clin Endocrinol Diabetes 104:447-453, 1996
38. Wutteke W: Dopaminergic action of extracts of agnus castus. Forschende Komplementarmedizen 6:329-330, 1996
39. Feldman HU, Albrecht M, Lamertz M, et al: The treatment of corpus luteum insufficiency and premenstrual syndrome. Experience in a multicenter study under clinical practice conditions. Gynakol 12:422-425, 1990
40. Dittmar G, Bohnert K: Premenstrual syndrome: Treatment with a phytopharmaceutical. TW Gynakol 5:60-68, 1992
41. Turner S, Mills S: A double-mind clinical trial on a herbal remedy for premenstrual syndrome: A case study. Complementary therapies in medicine. Complementary Therapies in Med 1:73-77, 1993
42. Schellenberg R: Treatment for the menstrual syndrome with agnus castus fruit extract: prospective, randomized, placebo controlled study. BMJ 322:134-137, 2001
43. Lauritzen C, Reuter H, Repges R: Treatment of premenstrual tension syndrome with vitex agnus castus: Controlled double blind study versus pyridoxine. Phytomedicine 4:183-189, 1997
44. Kemper K: The Longwood Herbal Task Force. Available at: www.mcp.edu/herbal/default.htm. Accessed June 10, 2002.
45. Horrobin DF, Manku MS, Brush M, et al: Abnormalities in plasma essential fatty acid levels in women with premenstrual syndrome and nonmalignant breast disease. J Nutr Med 2:259-264, 1991
46. Koshidawa N, Tatsuma T, Furyya K, et al: Prostaglandins and premenstrual syndrome. Progtaglansdin Leukkot Essent Fatty Acids 45:33-36, 1992
47. Budeiri D, Li Wan Po A, Dorman JC: Is evening primrose oil of value in the treatment of premenstrual synsdrome? Control Clin Trials 17:60-68, 1996
48. Collins A, Gerin A, Coleman G, et al: Essential fatty acids in the treatment of premenstrual syndrome. Obstet Gynec 81:93-98, 1993
49. Khoo SK, Munroe C, Battistutta D: Evening primrose and the treatment of prementrual syndrome. Med J Austr 153:189-190, 1990
50. Carter J, Verhoef MJ: Efficacy of self-help and alternative treatments of premenstrual syndrome. Womens Health Issues 4:130-137, 1994
51. Evening primrose. Available at: www.naturaldatabase.com. Accessed June 23, 2003.
52. Foster S: Black cohaosh (cimicifuga recemosa: a literature review). Herbal Gram 45:35-49, 1999
53. Lieberman S: A review of the effectiveness of cimicfuga racemosa(Black Cohaosh) for the symtoms of menopause. J Women's Health 7:525-529, 1998
54. Duker EM, Kopanski L, Jarry H, et al:Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats. Planta Med 57:420-424, 1991
55. Jacobson JS, Troxel AB, Evans J, et al: Randomized trial of black cohash for the treatment of hotflashes among women with a history of breast cancer. J Clin Oncol 19: 2739-7245, 2001
56. Liske E: Therapeutic efficacy and safety of cimicifuga racemosa for gynecologic disorders. Adv Ther 15:45-53, 1998
57. Black cohash. Available at: www.naturaldatabase.com. Accessed June 21, 2002
58. Gingko. Available at: www. naturaldatabase.com. Accessed June 23, 2002
59. Tamborini A, Taurelle R: Value of standardized ginkgo biloba extract (Egb 761) in the management of congestive symptoms of premenstrual syndrome. Rev Fr Gynecol Obstet 88:447-457, 1993
60. Brautigam MR, Blommaert FA, Verleye G, et al: Treatment of age-related memory complaints with Ggingko biloba extract: a randomized double blind placebo controlled study. Phytomedicine 5:425-434, 1998
61. Ranchon I, Gorrand JM, Cluzel J, et al: Functional protection of photoreceptors from light-induced damage by dimethylurea and gingko biloba extract. Invest Ophthalmol Vis Sci 40:1191-1199, 1999
62. Paick J, Lee J: An expiremental study of the effect of ginkgo biloba extract on the human and rabbit corpus cavernosum tissue. J Urol 156:1876-1880, 1996
63. FDA: Special Nutritional Adverse Event Monitoring System, USFDA. Available at: 1998.http://vm.cfsan.fda.gov/~dms/aems.html. Accessed June 16, 2002
64. Steiner M, Steinberg S, Stewart D, et al: Fluoxetine in the treatment of premenstrual dysphoria. Canadian fluoxetine/prementrual dysphoria Collaborative Study Group. NEJM 332:1529-1534, 1995
65. Williams JW, Mulrow CD, Chiquette E, et al: A systematic review of newer pharmacotherapies for depression in adults: Evidence report summary. Ann Intern Med 132: 743-756, 2000
66. Shelton RC, Keller MB, Gelenberg A, et al: Effectiveness of St. John's Wort in major depression: A randomized placebo controlled trial. JAMA 285:1978-1986, 2001
67. Stevinson C, Ernst E: A pilot study of hypercium perforatum for the treatment of premenstrual syndrome. BJOG 107:870-876, 2000
68. Lebot V, Merlin M, Lindstrom L: Kava: The Pacific Drug. New Haven, CT Yale University Press, 1992
69. Pittler MH, Ernst E: Efficacy of kava extract for treating anxiety: Systematic review and meta-analysis. J Clin Pharmacocol 20:84-89, 2000
70. Warnecke G: Psychosomatic dysfunctions in the female climacteric. Clinical effectiveness and tolerance of kava Extract WS 1490. Forschr Med 109:119-122, 1991
71. De Leo V, La Marca A, Lanzetta D, et al: Assessment of the association of Kava-kava extract and hormone replacement therapy in the treatment of postmenopausal anxiety. Minerva Ginecologica 52:263-267, 2000
72. De Leo, La Marca A, Morgante G, et al: Evaluation of combining kava extract with hormone replacement therapy in the treatment of postmenopausal anxiety. Maturitas 39:185-188, 2001
73. Blumenthal M: Expert analysis of case reports says there is insufficient evidence to make a causal connection. Available at: herbalgram.org. Accessed April 8, 2002
74. Packer-Tursman J: Anxiety over kava: FDA, others investigate reports of liver toxicity. Washington Post, Jan 22, 2002
75. Swensen JN: Man convicted of driving under the influence of Kava. Salt Lake City, UT, Deseret News, 1996
76. Low Dog T: Integrative treatments for premenstrual syndrome. J Altern Therapies Health Healing 7:32-39, 2001
77. Levitt A, Kohasu W, eds: Premenstrual syndrome. Complementary and Alternative Medicine Secrets, Philadelphia, PA, Hanley and Belfus, 2002
78. Hunter M, Swann C, Ussher JM: Seeking help for premenstrual syndrome: Women's self-reports and treatment. Sexual Marital Therapy 10:253-262, 1995
79. Benson H: The relaxation Response. New York, NY, William Morrow and Company, Inc, 1977, p 114
80. Barrows KA, Jacobs BP: Mind-body medicine. An introduction and review of the literature. Med Clin North Am 86:11-31, 2002
81. Goodale IL, Domar AD, Benson H: Alleviation of premenstrual syndrome symptoms with the relaxation response. Obstret Gynecol 75:649-655, 1990
82. Van Zak DB: Biofeedback treatments for the premenstrual and premenstrual affective syndromes. Int J Psychosom 41:53-60, 1994
83. Groer M, Ohnesorge C: Menstrual-cycle lengthening and reduction in premenstrual distress through guided imagenary. J Holistic Nurs. 11:286-294, 1993
84. Blake F, Salkovskis P, Gath D, et al: Cognitive therapy for premenstrual syndrome: a controlled trial. J Psychosom Res 45:307-318, 1998
85. Morse CA, Dennerstein L, Farrell E, et al: A comparison of hormone therapy, coping skills training, relaxation for the relief of premenstrual syndrome. Behav Med 14:469-489, 1991
86. Kirkby RJ: Changes in premenstrual symptoms and irrational thinking following cognitive-behavioral skills training. J Consult Clin Psychol 62:1026-1032, 1994
87. Christensen AP, Oei TP: The efficacy of cognitive behavior therapy in treating premenstrual dysphoric changes. J Affect Disord 33:57-63, 1995
88. Morse C, Bernard ME, Dennerstein L: The effects of rational-emotive therapy and relaxation training on premenstrual syndrome: A preliminary study. J Rational-Emotive Cognitive Behav Therapy Sum 7;78-110, 1989
89. Sridevi K, Krishna Rao PV: Yoga practice and menstrual distress. J Indian Acad Applied Psychol 22:47-54, 1996
90. Pullon SR, Reinken JA, Sparrow MJ: Treatment of premenstrual symptoms in Wellington women. NZ Med J 1029862:72-74, 1989
91. Aganoff JA, Boyle GJ: Aerobic exercise, mood states, and menstrual cycle symptoms. J Psychosom Res 38:183-192, 1994
92. Choi PY, Salmon P: Symptoms changes across the menstrual cycle in competitive sportswomen, exercisers and sedentary women. Soc Sci Med 41:769-777, 1995
93. Prior JC, Vigna Y, Sciarretta D, et al: Conditioning exercise decreases premenstrual symptoms: a prospective controlled 6 month trial. Fertil Steril 47:402-408, 1987
94. Steege JF, Blumenthal JA: The effects of aerobic exercise on premenstrual symptoms in middle-age women: A preliminary study. J Psychosom Res 37:127-133, 1993
95. Parry BL, Haynes P: Mood disorders and the reproductive cycle. J Gender-Specific Med 3:53-58, 2000
96. Parry BL, Udell C, Elliott JA, et al: Blunted phase-shift responses to morning bright light in premenstrual dysphoric disorders. J Biol Rhythms 12:443-456, 1997
97. Lam RW, Carter D, Misri S, et al: A controlled study of light therapy in women with late luteal phase dysphoric disorder. Psychiatry Res 86:185-192, 1999
98. Parry BL, Mahan AM, Mostofi N, et al: Light theraphy of late luteal phase dysphoric disorder: an extended study. Am J Psychiatry 150:1417-1419, 1993
99. Hernandez-Reif M, Martinez A, Field T, et al: Premenstrual symptoms are relieved by massage therapy. J Psychosom Obstet Gynaecol 21:9-15, 2000
100. Oleson T, Flocco W: Randomised controlled study of premenstrual symptoms treated with ear, hand, and foot reflexology. Acta Obstet Gynec Scand 50:331-337, 1971
101. Walsch MJ, Polus BI: A randomized, placebo-controlled clinical trial on the efficacy of chiropractic therapy on premenstrual syndrome. J Manipulative Physiol Ther 22: 582-585, 1999
102. Yakir M, Kreitler S, Brzezinski A, et al: Effects of homeopathic treatment in women with premenstrual syndrome: apilot study. Br Homeopathic J 90:148-153, 2001